Results 311 to 320 of about 124,517 (353)
Some of the next articles are maybe not open access.
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
American Journal of Gastroenterology, 2019Cholestatic liver diseases encompass a broad spectrum of pathologies, with the core injury occurring at the level of cholangiocytes and progressing to hepatic fibrosis and liver dysfunction. Primary biliary cholangitis and primary sclerosing cholangitis are the most significant progressive cholangiopathies in adults. Although rare, they commonly evolve
Raquel T, Yokoda, Elizabeth J, Carey
openaire +2 more sources
Infectious Disease Clinics of North America, 1992
Acute cholangitis is a clinical syndrome marked by fever, jaundice, and abdominal pain that develops because of stasis and infection in the biliary tract. Patients with cholangitis may present with symptoms ranging from a mild, recurrent illness to overwhelming sepsis.
openaire +2 more sources
Acute cholangitis is a clinical syndrome marked by fever, jaundice, and abdominal pain that develops because of stasis and infection in the biliary tract. Patients with cholangitis may present with symptoms ranging from a mild, recurrent illness to overwhelming sepsis.
openaire +2 more sources
EASL Clinical Practice Guidelines on Sclerosing Cholangitis.
Journal of Hepatology, 2022O. Chazouilleres +7 more
semanticscholar +1 more source
Primary Sclerosing Cholangitis
2011Primary sclerosing cholangitis (PSC) is a chronic liver condition which may affect both intra and extrahepatic biliary tree. Etiology of PSC remains to be fully elucidated but genetic, autoimmune, inflammatory and possibly infective factors could all contribute to its development.
Piotr, Milkiewicz, Ewa, Wunsch
openaire +2 more sources
The Lancet Gastroenterology and Hepatology, 2019
BACKGROUND The aim of this study was to evaluate the long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis using 3-year interim data from the 5-year open-label extension of the pivotal phase 3 POISE trial ...
M. Trauner +11 more
semanticscholar +1 more source
BACKGROUND The aim of this study was to evaluate the long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis using 3-year interim data from the 5-year open-label extension of the pivotal phase 3 POISE trial ...
M. Trauner +11 more
semanticscholar +1 more source
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
Seminars in liver disease (Print), 2019Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction of small to medium size intrahepatic bile ducts. The etiology of PBC remains unknown and pathogenesis features immune-mediated biliary injury,
A. Lleo +3 more
semanticscholar +1 more source